Nanogen Inc. Granted Two New Patents on Proteomics and Diagnostics
Filed in archive Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics , Patents and Intellectual Property Rights by Creative Weblogging on April 18, 2006
"These patents are the result of discoveries that were made in our proteomics research programs," said Howard C. Birndorf, Nanogen chairman and chief executive officer. "These intellectual property assets can be leveraged by Nanogen to develop advanced diagnostic products and could be licensed by potential pharma partners who are looking for novel approaches to treat Alzheimer's disease or metabolic disorders."Advanced technologies from Nanogen, including real-time PCR reagents, the NanoChip® electronic microarray platform and a line of rapid, point-of-care diagnostic tests, provide researchers, clinicians and physicians worldwide with improved methods and tools to predict, diagnose, and ultimately help treat disease. Source: PR Newswire
About the author: Gloria
is a chemist and blogs at Straight From The Doc,The Pharm Voice, and Filipina Soul
Permalink: Nanogen Inc. Granted Two New Patents on Proteomics and Diagnostics
Tags:
patent proteomics biotech patents nanogen proteomics+diagnostics patents+proteomics nanogen+granted
Trackback:






